Researchers at the Singapore Immunology Network at A*STAR have found that immune dendritic cells are crucial for the development of…
Magdalena Kegel
Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Magdalena Kegel
Sometimes, looking backward is a good way to go forward. With this in mind, scientists discovered that a cancer drug approved decades…
Anthera Pharmaceuticals recently announced that the last patient in the company’s Phase 3 clinical trial, evaluating blisibimod for the treatment…
Scientists at The Scripps Research Institute identified key mechanisms contributing to the generation of autoimmune B-cells that attack the…
Pregnancy in patients suffering from systemic lupus erythematosus (SLE) can be complicated by a range of factors affecting both the…
Researchers at have identified an RNA molecule, known as a long noncoding RNA, that is responsible for controlling innate immune…
Non-Europeans more often carry genes increasing the likelihood of developing systemic lupus erythematosus (SLE), explaining the higher disease rates observed…
Anthera Pharmaceuticals reported that the company’s Phase 3 clinical trial of blisibimod in patients with severe systemic lupus erythematosus (SLE) began…
Scientists at Bristol-Myers Squibb have uncovered mechanisms explaining why African-Americans with systemic lupus erythematosus (SLE) experience more serious symptoms…
San Francisco-based Thunderbolt — the first company established by Vitesse Biologics — has attained the rights to Astellas…